Clinical Trial Update: ReWalk Personal Device Postmarket Study

View source ↗

Summary

This document provides an update on the postmarket study of the ReWalk Personal Device for spinal cord injury patients. The current study status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Snippet

Sponsor: ReWalk Robotics, Inc. | Conditions: Injuries, Spinal Cord | Status: UNKNOWN